Hologic (HOLX) Could See Pressure As Group Urges Mammograms at 50, Not 40
More News related to HOLX
- Hologic to Present at the Raymond James 31st Annual Institutional Investors Conference
- Highlights From HOLX's Q1 Conference Call: Guides Above for Q2 Revenues; In-line for FY10
- Soleil Securities Upgrades Hologic (HOLX) to Hold
- After-Hours Movers 2/1: BKS, RTEC, ARRY, CCK Higher; STSA, CDR, ICUI, ADVS Lower
- Hologic (HOLX) Posts Q1 Adj.-EPS of $0.29, Tops by 3c
More News related to Insiders' Blog
- Sprint (S): Q4 Earnings Preview
- NYSE Euronext (NYX) Beats the Street's Q4 Views on Both the Top and Bottom Lines
- Q1 Earnings Preview: Walt Disney (DIS)
- S&P Revises Credit Outlooks On BofA (BAC) and Citi (C) to Negative, Saying No More Free Govenment Handouts
- Airline Stocks Taking-Off as UAL Reports Strong Monthly Traffic Results; Investors Shrug at Flight Delays (UAUA, DAL, LUV, AMR, more)
Hologic Inc. (Nasdaq: HOLX) could be under pressure after an infulencial group set new guidlines for mammograms, saying they should be given at age 50, not 40. The group also said women age 50 to 74 should have mammograms less frequently every two years, rather than every year.
Related Categories
Insiders' BlogTrader Talk
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
